Blackstone Inc’s ESSA Pharma EPIX Stock Holding History

Blackstone Inc’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,003,103	Closed	-$6.31M	–	228
2022 Q2	$6.31M	Hold	2,003,103	–	–	0.02%	97
2022 Q1	$12.4M	Sell	2,003,103 -1,300,000	-39%	-$11.4M	0.03%	93
2021 Q4	$46.9M	Hold	3,303,103	–	–	0.12%	68
2021 Q3	$26.4M	Hold	3,303,103	–	–	0.06%	93
2021 Q2	$94.4M	Sell	3,303,103 -269,950	-8%	-$7.85M	0.21%	54
2021 Q1	$104M	Hold	3,573,053	–	–	0.21%	46
2020 Q4	$42.6M	Hold	3,573,053	–	–	0.15%	51
2020 Q3	$24.7M	Buy	3,573,053 +200,000	+6%	+$1.36M	0.1%	57
2020 Q2	$20.9M	Hold	3,373,053	–	–	0.09%	56
2020 Q1	$13.5M	Hold	3,373,053	–	–	0.1%	39
2019 Q4	$18.6M	Hold	3,373,053	–	–	0.12%	26
2019 Q3	$11.4M	Buy	3,373,053 +1,704,493	+102%	+$4.21M	0.07%	33
2019 Q2	$4.09M	Hold	1,668,560	–	–	0.02%	57
2019 Q1	$5.67M	Hold	1,668,560	–	–	0.03%	50
2018 Q4	$3.5M	Buy	+1,668,560	New	+$4.89M	0.02%	39

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Blackstone Inc's EPIX Position: Q3 2022 in Review

Blackstone Inc sold out of ESSA Pharma (EPIX) in Q3 2022, closing a stake of 2,003,103 shares — an estimated $6.31M sold.

Blackstone Inc first reported a position in EPIX in Q4 2018 and held it in 15 quarters. The position peaked at $104M in Q1 2021. 54 funds tracked by Wall St. Rank hold EPIX as of Q3 2022.

Blackstone Inc reported no remaining ESSA Pharma position as of Q3 2022 after selling out during the quarter.
Blackstone Inc sold 2,003,103 ESSA Pharma shares in Q3 2022, an estimated $6.31M.
Blackstone Inc first reported a position in ESSA Pharma in Q4 2018 and held it in 15 quarters.
Blackstone Inc's ESSA Pharma position peaked at $104M in Q1 2021.
54 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2022.

Based on Blackstone Inc's 13F filing for Q3 2022, filed 14 Nov 2022.